CAMBRIDGE, England & BOSTON, June 03, 2025--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on June 2, 2025, the Compensation Committee of the company’s Board of Directors granted ...

Bicycle Therapeutics plc (NASDAQ: BCYC), currently valued at $557.5 million and trading near $8.05, is a biotechnology company specializing in developing innovative cancer treatments.

CAMBRIDGE, England& BOSTON---- Bicycle Therapeutics plc, today announced that on June 2, 2025, the Compensation Committee of the company’ s Board of Directors granted to seven new employees ...

Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on June 2, 2025, the Compensation Committee of the company’s Board of Directors granted to seven new employees inducement awards ...

CAMBRIDGE, England & BOSTON, June 03, 2025--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on June 2, 2025, the Compensation Committee of the company’s Board of Directors granted to ...

We cover the latest Bicycle Therapeutics headlines and breaking news impacting Bicycle Therapeutics stock performance. Investing.com - Financial Markets Worldwide Open in App ...

A high-level overview of Bicycle Therapeutics plc (BCYC) stock. View (BCYC) real-time stock price, chart, news, analysis, analyst reviews and more.

UK biotech Bicycle Therapeutics has raised £40 million ($52m) in a new funding round to help it progress its pipeline, including its lead compound, a first-in-class cancer treatment.

World Bicycle Day 2025: Observed every year on June 3, World Bicycle Day celebrates over two centuries of the bicycle’s impact on mobility and culture. Across the globe, this day encourages people to ...

The plan to install bike lanes and reduce vehicle lanes has drawn the ire of neighbors, who recently filed a lawsuit to ...